Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1936 1
1946 4
1947 1
1950 1
1951 5
1952 4
1953 5
1954 3
1955 2
1956 2
1957 2
1958 1
1959 4
1960 1
1961 2
1962 4
1964 2
1965 3
1966 3
1967 2
1968 4
1969 4
1970 4
1971 1
1972 2
1973 1
1975 2
1976 4
1977 4
1978 3
1979 1
1980 5
1981 6
1982 6
1983 5
1984 3
1985 1
1986 3
1987 4
1988 3
1989 3
1990 3
1991 3
1992 2
1993 1
1994 4
1995 11
1996 3
1997 4
1998 6
1999 4
2000 5
2001 7
2002 7
2003 9
2004 10
2005 8
2006 9
2007 12
2008 14
2009 19
2010 17
2011 22
2012 21
2013 30
2014 15
2015 30
2016 33
2017 24
2018 37
2019 32
2020 31
2021 28
2022 34
2023 13

Text availability

Article attribute

Article type

Publication date

Search Results

581 results

Results by year

Filters applied: . Clear all
Page 1
Role of host factors in SARS-CoV-2 entry.
Evans JP, Liu SL. Evans JP, et al. J Biol Chem. 2021 Jul;297(1):100847. doi: 10.1016/j.jbc.2021.100847. Epub 2021 May 28. J Biol Chem. 2021. PMID: 34058196 Free PMC article. Review.
Reverse total shoulder arthroplasty.
Burden EG, Batten TJ, Smith CD, Evans JP. Burden EG, et al. Among authors: evans jp. Bone Joint J. 2021 May;103-B(5):813-821. doi: 10.1302/0301-620X.103B.BJJ-2020-2101. Epub 2021 Feb 22. Bone Joint J. 2021. PMID: 33616421
Enhanced neutralization resistance of SARS-CoV-2 Omicron subvariants BQ.1, BQ.1.1, BA.4.6, BF.7, and BA.2.75.2.
Qu P, Evans JP, Faraone JN, Zheng YM, Carlin C, Anghelina M, Stevens P, Fernandez S, Jones D, Lozanski G, Panchal A, Saif LJ, Oltz EM, Xu K, Gumina RJ, Liu SL. Qu P, et al. Among authors: evans jp. Cell Host Microbe. 2023 Jan 11;31(1):9-17.e3. doi: 10.1016/j.chom.2022.11.012. Epub 2022 Nov 22. Cell Host Microbe. 2023. PMID: 36476380 Free PMC article.
Neutralization of the SARS-CoV-2 Omicron BA.4/5 and BA.2.12.1 Subvariants.
Qu P, Faraone J, Evans JP, Zou X, Zheng YM, Carlin C, Bednash JS, Lozanski G, Mallampalli RK, Saif LJ, Oltz EM, Mohler PJ, Gumina RJ, Liu SL. Qu P, et al. Among authors: evans jp. N Engl J Med. 2022 Jun 30;386(26):2526-2528. doi: 10.1056/NEJMc2206725. Epub 2022 Jun 15. N Engl J Med. 2022. PMID: 35704428 Free PMC article. No abstract available.
SARS-CoV-2 spreads through cell-to-cell transmission.
Zeng C, Evans JP, King T, Zheng YM, Oltz EM, Whelan SPJ, Saif LJ, Peeples ME, Liu SL. Zeng C, et al. Among authors: evans jp. Proc Natl Acad Sci U S A. 2022 Jan 4;119(1):e2111400119. doi: 10.1073/pnas.2111400119. Proc Natl Acad Sci U S A. 2022. PMID: 34937699 Free PMC article.
Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics.
Kalia SS, Adelman K, Bale SJ, Chung WK, Eng C, Evans JP, Herman GE, Hufnagel SB, Klein TE, Korf BR, McKelvey KD, Ormond KE, Richards CS, Vlangos CN, Watson M, Martin CL, Miller DT. Kalia SS, et al. Among authors: evans jp. Genet Med. 2017 Feb;19(2):249-255. doi: 10.1038/gim.2016.190. Epub 2016 Nov 17. Genet Med. 2017. PMID: 27854360 Free article.
Neutralization of SARS-CoV-2 Omicron sub-lineages BA.1, BA.1.1, and BA.2.
Evans JP, Zeng C, Qu P, Faraone J, Zheng YM, Carlin C, Bednash JS, Zhou T, Lozanski G, Mallampalli R, Saif LJ, Oltz EM, Mohler PJ, Xu K, Gumina RJ, Liu SL. Evans JP, et al. Cell Host Microbe. 2022 Aug 10;30(8):1093-1102.e3. doi: 10.1016/j.chom.2022.04.014. Epub 2022 Apr 25. Cell Host Microbe. 2022. PMID: 35526534 Free PMC article.
Elective Cancer Surgery in COVID-19-Free Surgical Pathways During the SARS-CoV-2 Pandemic: An International, Multicenter, Comparative Cohort Study.
Glasbey JC, Nepogodiev D, Simoes JFF, Omar O, Li E, Venn ML, Pgdme, Abou Chaar MK, Capizzi V, Chaudhry D, Desai A, Edwards JG, Evans JP, Fiore M, Videria JF, Ford SJ, Ganly I, Griffiths EA, Gujjuri RR, Kolias AG, Kaafarani HMA, Minaya-Bravo A, McKay SC, Mohan HM, Roberts KJ, San Miguel-Méndez C, Pockney P, Shaw R, Smart NJ, Stewart GD, Sundar Mrcog S, Vidya R, Bhangu AA; COVIDSurg Collaborative. Glasbey JC, et al. Among authors: evans jp. J Clin Oncol. 2021 Jan 1;39(1):66-78. doi: 10.1200/JCO.20.01933. Epub 2020 Oct 6. J Clin Oncol. 2021. PMID: 33021869 Free PMC article.
Treatment with soluble CD24 attenuates COVID-19-associated systemic immunopathology.
Song NJ, Allen C, Vilgelm AE, Riesenberg BP, Weller KP, Reynolds K, Chakravarthy KB, Kumar A, Khatiwada A, Sun Z, Ma A, Chang Y, Yusuf M, Li A, Zeng C, Evans JP, Bucci D, Gunasena M, Xu M, Liyanage NPM, Bolyard C, Velegraki M, Liu SL, Ma Q, Devenport M, Liu Y, Zheng P, Malvestutto CD, Chung D, Li Z. Song NJ, et al. Among authors: evans jp. J Hematol Oncol. 2022 Jan 10;15(1):5. doi: 10.1186/s13045-021-01222-y. J Hematol Oncol. 2022. PMID: 35012610 Free PMC article. Clinical Trial.
581 results